Consensus Lexaria Bioscience Corp.

Equities

LEXX

US52886N4060

Real-time Estimate Cboe BZX Other stock markets 01:11:16 2024-04-30 pm EDT			5-day change	1st Jan Change
2.88 ^USD	+17.07%		+29.15%	+131.44%

Apr. 16	Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study	MT
Apr. 16	Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study	CI

Evolution of the average Target Price on Lexaria Bioscience Corp.

Price target over the last 5 years

History of analyst recommendation changes

7e9e864f253bae66c0c10299d96d.O6vnrJVUvVW11V-F7NtwshOUQyRZiu_1iRcet2dUkqI.Tvjf9KQ-0wHY4j7A3rUo2j7yF0UT5Y6N4FJb3R0B85AI3ZWB2RmIAP2eaw~c136f4500de302f1dae1d218f58e26be

Analyst Recommendations on Lexaria Bioscience Corp.

Maxim Group Adjusts Lexaria Bioscience Price Target to $12 From $3, Maintains Buy Rating	Mar. 05	MT
Maxim Group Initiates Lexaria Bioscience With Buy Rating, $2 Price Target	23-07-21	MT